BlackRock Fund Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

BlackRock Fund Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$48.2M	Buy	794,666 +76,026	+11%	+$4.65M	0.01%	1708
2016 Q3	$47.7M	Buy	718,640 +57,809	+9%	+$3.62M	0.01%	1609
2016 Q2	$36.9M	Buy	660,831 +13,093	+2%	+$636K	0.01%	1696
2016 Q1	$21.8M	Buy	647,738 +12,401	+2%	+$421K	0.01%	1937
2015 Q4	$28.7M	Sell	635,337 -8,634	-1%	-$372K	0.01%	1827
2015 Q3	$25.4M	Buy	643,971 +12,315	+2%	+$701K	0.01%	1838
2015 Q2	$39.2M	Buy	631,656 +26,898	+4%	+$1.6M	0.01%	1688
2015 Q1	$37.8M	Buy	604,758 +281,637	+87%	+$17.1M	0.01%	1696
2014 Q4	$18.2M	Buy	323,121 +158,097	+96%	+$6.97M	﹤0.01%	2119
2014 Q3	$4.67M	Sell	165,024 -4,193	-2%	-$126K	﹤0.01%	2795
2014 Q2	$5.83M	Buy	+169,217	New	+$5.31M	﹤0.01%	2752

Other funds holding ANIP

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Fund Advisors's ANIP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its ANI Pharmaceuticals (ANIP) stake by 11% in Q4 2016, buying an estimated $4.65M and bringing the position to 794,666 shares worth $48.2M. The position accounts for 0.01% of the portfolio, ranked #1708.

BlackRock Fund Advisors first reported a position in ANIP in Q2 2014 and has held it in 11 quarters since. 157 funds tracked by Wall St. Rank hold ANIP as of Q4 2016.

BlackRock Fund Advisors held 794,666 shares of ANI Pharmaceuticals worth $48.2M as of Q4 2016.
BlackRock Fund Advisors bought 76,026 ANI Pharmaceuticals shares in Q4 2016, an estimated $4.65M.
ANI Pharmaceuticals made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1708 holding.
BlackRock Fund Advisors first reported a position in ANI Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
157 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.